share_log

Cantor Fitzgerald Maintains Overweight on VolitionRX, Raises Price Target to $2.5

Benzinga ·  Nov 16, 2023 09:31

Cantor Fitzgerald analyst Ross Osborn maintains VolitionRX (AMEX:VNRX) with a Overweight and raises the price target from $2.1 to $2.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment